Will AI Finally Defeat Chronic Diseases Like Alzheimer’s?

Will AI Finally Defeat Chronic Diseases Like ...

Suivant

BONUS: Explore More About AI

Even though Imagine This... has come to an end, you can still join BCG as we explore AI on our sister podcast, The So What from BCG. https://lnk.to/so-what-general-show10Here we share an excerpt from a recent episode, "How BCG Is Rewriting Its Talent Playbook in the Age of AI,"wh ...  Afficher plus

BONUS EPISODE: Working with AI Agents

We just closed the books on Imagine This season two and the series. But we aren’t done quite yet! In this bonus episode, we're going to peel back the curtain and speak with Bill Moore and GENE about working with agents, what we've learned, and where all of this is heading.Learn M ...  Afficher plus

Épisodes Recommandés

Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology
Science and Technology

"Pharmaceutical Breakthroughs: The Cutting Edge of Biotechnology" - In this episode, we dive deep into the revolutionary world of biotechnology and its transformative impact on pharmaceuticals. Discover how cutting-edge innovations are reshaping drug development, accelerating vac ...  Afficher plus

Introducing: The Future of Aging
The World as You’ll Know It: The Future Of Aging

Human beings are living longer than ever. Thanks to advances like vaccines, antibiotics, pasteurized milk and clean water, we’ve added more than 30 years to the average lifespan over the last 120 years. That’s more than was added in the previous 10,000 years combined. More recent ...  Afficher plus

Driving Disease Risk Prediction and Preventative Healthcare with AI - with Dan Elton of the National Human Genome Research Institute
The AI in Business Podcast

Today's guest is Dan Elton, Staff Scientist at the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH). Dan returns to explore the transformative role of AI in healthcare. In his new role, Dan shares how his work at NIH focuses on integr ...

  Afficher plus

How AI Will Accelerate Breakthroughs in Biotechnology with Benchling CEO Sajith Wickramasekara
No Priors: Artificial Intelligence | Technology | Startups

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  Afficher plus